# Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.

> **NCT05062421** · — · RECRUITING · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 540 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05062421
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062421, "Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05062421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*